Expanding Patient Access to Investigational Drugs Single Patient Investigational New Drug and the “Right to Try”

Overview of attention for article published in JACC: Basic to Translational Science, May 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (64th percentile)

So far, Altmetric has seen 2 public wall posts from 2 users.

Editors’ Insights: Expanding access to investigational drugs using single patient INDs and the “Right to Try?" Learn more in…

With drug approval times taking an average of 8 years from entry into clinical trials to full U.S. Food and Drug Administration …